Clinical Trial Update: Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and efficacy of combining Brinzolamide and Dorzolamide dosed three times daily to reduce intraocular pressure in open-angle …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Brinzolamide (Brinzolamide)
• Dorzolamide (Dorzolamide)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED